This study aimed to identify the cause of azoospermia in a 38-year-old infertile man who was referred for genetic testing. Cytogenetic evaluation was performed by G-banding, C-banding, and FISH using centromeric probes for chromosomes X and Y and showed the presence of a monocentric isochromosome Y with a complex, mosaic karyotype 45,X/46,X,i(Y)(q10)/46,XX/47,XX,i(Y)(q10). Multiplex PCR for the commonly deleted genes in the AZFa, AZFb, and AZFc regions of the Y chromosome was performed and indicated the presence of all 3 regions. Further, PCR amplification followed by DNA sequencing of the SRY gene was done, which ruled out mutations in that gene. To identify the position of the SRY gene, FISH using a locus-specific probe was used and showed that the gene had been translocated to chromosome 3. Subtelomere FISH for 3q and Yp evidenced that the subtelomeric region of the Y chromosome was found on the terminal region of 3q. The clinical symptoms of the patient can be attributed to this abnormal genotype. The importance of genetic testing in infertile patients and the need for genetic counselling to prevent the transmission of the defect are emphasized.

Keywords:
Azoospermia, Isochromosome, Male infertility, Mosaicism
1.
Abulhasan S, Tayel S, Al-Awadi S: Mosaic Turner syndrome: cytogenetics versus FISH. Ann Hum Genet 63:199-206 (1999).
2.
Akinsal EC, Baydilli N, Demirtas A, Saatci C, Ekmekcioglu O: Ten cases with 46,XX testicular disorder of sex development: single center experience. Int Braz J Urol 43:770-775 (2017).
3.
Alves C, Carvalho F, Cremades N, Sousa Mand Barros A: Unique (Y;13) translocation in a male with oligozoospermia: cytogenetic and molecular studies. Eur J Hum Genet 10:467-474 (2002).
4.
Caglayan A O, Demiryilmaz F, Kendirci M, Ozyazgan I, Akalin H, et al: Mixed gonadal dysgenesis with 45,X/46,X,idic(Y)/46,XY,idic(Y) karyotype. Genet Couns 20:173-179 (2009).
5.
Chien S, Li Y, Ho M, Hsu P, Teng R, et al: Rare rearrangements: a ‘‘jumping satellite'' in one family and autosomal location of the SRY gene in an XX Male. Am J Med Genet A149A:2775-2781 (2009).
6.
Dale B, Wilding M, De Matteo L, Zullo F: Absence of sperm sex chromosome aneuploidies in an X0/XYY man. Fertil Steril 78:634-636 (2002).
7.
Ferguson-Smith MA, Boyd E, Ferguson-Smith ME, Pritchard JG, Yusuf AM, et al: Isochromosome for long arm of Y chromosome in patient with Turner's syndrome and sex chromosome mosaicism (45,X/46,XYqi). J Med Genet 6:422-425 (1969).
8.
Francisco L, Braga D, Figueira R, Madaschi C, Pasqualotto FF, et al: Assisted reproductive technology outcomes in azoospermic men: 10 years of experience with surgical sperm retrieval. Aging Male 13:44-50 (2010).
9.
Haaf T, Schmid M: Y isochromosome associated with a mosaic karyotype and inactivation of the centromere. Hum Genet 85:486-490 (1990).
10.
Hsu L: Phenotype/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. Am J Med Genet 53:108-140 (1994).
11.
ISCN 2016: An International System for Human Cytogenomic Nomenclature; McGowan-Jordan J, Simons A, Schmid M (eds). Cytogenet Genome Res 149:1-140 (2016).
12.
Jiang Y, Wang R, Li L, Xue L, Deng Set, al: Molecular‑cytogenetic study of de novo mosaic karyotype 45,X/46,X,i(Yq)/46,X,idic(Yq) in an azoospermic male: case report and literature review. Mol Med Rep 16:3433-3438 (2017).
13.
Kilic S, Yukse B, Ozdemir E, Yesilyurt A, Tasdemir Net, al: Assisted reproductive treatment applications in men with normal phenotype but 45,X/46,XY mosaic karyotype: clinical and genetic perspectives. Taiwan J Obstet Gynecol 49:199-202 (2010).
14.
Kruse R, Guttenbach M, Schartmann B, Schubert R, Ven H, et al: Genetic counseling in a patient with XXY/XXXY/XY mosaic Klinefelter's syndrome: estimate of sex chromosome aberrations in sperm before intracytoplasmic sperm injection. Fertil Steril 69:482-485 (1998).
15.
Li P, Ding L, Sha Y, Song Y, Lin J, et al: Non-chimerism and chimerism pseudo dicentric Y chromosome: two case reports about azoospermia and cytogenetic/molecular genetic analysis in the Chinese population. J Assist Reprod Genet 30:539-546 (2013).
16.
Morel F, Duguépéroux I, McElreavey K, Bris M J, Herry A, et al: Transmission of an unbalanced (Y;1) translocation in Brittany, France. J Med Genet 39:e52 (2002).
17.
Nailwal M, Chauhan J: Gene scanning for microdeletions in the azoospermia factor region of Y-chromosome in infertile men of Gujarat, India. J Clin Diagn Res 11:GC01-GC06 (2017).
18.
Neto F, Bach P, Najari B, Li P, Goldstein M: Genetics of male infertility. Curr Urol Rep 17:70 (2016).
19.
Okada H, Dobashi M, Yamazaki T, Fujisawa M, Arakawa S, et al: Fluorescence in situ hybridization analysis of sex-chromosome mosaicism in azoospermic men. J Androl 22:970-972 (2001).
20.
Pylyp L, Spinenko L, Verhoglyad N, Zukin V: Chromosomal abnormalities in patients with oligozoospermia and non-obstructive azoospermia. J Assist Reprod Genet 30:729-732 (2013).
21.
Ren H, Chow V, Ma S: Meiotic behaviour and sperm aneuploidy in an infertile man with a mosaic 45,X/46,XY karyotype. Reprod Biomed Online 31:783-789 (2015).
22.
Sachdeva K, Saxena R, Majumdar A, Chadda S, Verma I: Use of ethnicity-specific sequence tag site markers for Y chromosome microdeletion studies. Genet Test Mol Biomarkers 15:451-459 (2011).
23.
Soini S, Ibarreta D, Anastasiadou V, Ayme S, Braga S, et al: The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Eur J Hum Genet 14:588-645 (2006).
24.
Taylor M, Gardner H, Ezrin C: Isochromosome for the long arm of the Y in an infertile male. Hum Genet 40:227-230 (1978).
25.
Vijayalakshmi J, Venkatchalam P, Paul S, Rani G, Kumarasamy P, Kannan J: Chromosomal anomalies in patients with azoospermia and oligoasthenoteratozoospermia. Int J Hum Genet 11:117-121 (2011).
26.
Yu XW, Wei ZT, Jiang YT, Zhang SL: Y chromosome azoospermia factor region microdeletions and transmission characteristics in azoospermic and severe oligozoospermic patients. Int J Clin Exp Med 8:14634-14646 (2015).
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.